Live feed07:00:00·18hPRReleasevia QuantisnowEledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with TacrolimusByQuantisnow·Wall Street's wire, on your screen.ELDN· Eledon Pharmaceuticals Inc.Health Care
